Loerrach, Germany

Ulrike Hille


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrike Hille: Innovator in Selective CYP11B1 Inhibitors

Introduction

Ulrike Hille, an accomplished inventor based in Loerrach, Germany, has made significant contributions to the field of pharmaceuticals with her groundbreaking patent related to selective CYP11B1 inhibitors. With one patent to her name, she focuses on innovative treatments for cortisol-dependent diseases.

Latest Patents

Ulrike Hille's notable patent is titled "Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases." This invention pertains to compounds that selectively inhibit CYP11B1 while avoiding substantial inhibition of CYP11B2, CYP17, and CYP19. These compounds hold potential for treating conditions such as Cushing's syndrome and various metabolic diseases, offering hope for patients affected by these challenging disorders.

Career Highlights

Ulrike Hille is associated with the Universitaet des Saarlandes in Campus Saarbruecken, where she engages in research and innovation in the pharmaceutical domain. Her work exemplifies her commitment to advancing medical therapies through rigorous scientific exploration.

Collaborations

In her professional journey, Ulrike collaborates with esteemed colleagues, including Rolf Wolfgang Hartmann and Christina Zimmer. These partnerships enhance her research endeavors and contribute to the development of effective therapeutic solutions.

Conclusion

Ulrike Hille's innovative patent on selective CYP11B1 inhibitors showcases her dedication to addressing critical health issues. Through her work at the Universitaet des Saarlandes, she continues to push the boundaries of medical science, making her a noteworthy inventor in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…